INTS vs KMX · $7.7M cap vs P/E 19, rev $26.35B
Intensity Therapeutics, Inc. Common stock (INTS) versus CarMax Inc (KMX) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported KMX revenue for 2025-02-28 was $26.35B. Net income was $500.6M. Revenue was down 0.7% from 2024-02-29 to 2025-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
INTS currently screens at market cap $7.7M. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Not investment advice. Open the INTS and KMX stock pages for the full models.
Not investment advice.